This is a smoking cessation treatment study. Half of all study participants will receive standard smoking cessation therapy including nicotine replacement patches and asked to participate in a 75 minute virtual exercise. All participants will be asked to provide daily logs of smoking behavior for 28 days.

Many people who use e-cigarettes want to quit vaping; however, there is a lack of research on how to support e-cigarette quit attempts. This study will collect information on how e-cigarette users and their medical providers feel about quitting vaping and what strategies might work. We will also test how well nicotine replacement therapy (patches and lozenges), alongside a self-help booklet based off quitting smoking, work in helping people reduce or quit their e-cigarette use.

Cigarette smoking is a significant public health concern. Transcranial magnetic stimulation (TMS) is a non-invasive form of brain stimulation that has already displayed remarkable potential for producing novel, non-pharmacological interventions for depression and cigarette smokers. In this study, we will use brain MRI to guide TMS therapy for smoking cessation.

The aim of the proposed study is to assess how adding messaging to cigarette packages about filter vents and filters influences respondents awareness of filter ventilation, beliefs about the function of filter vents and filters, smoking behavior, ratings of cigarette satisfaction, smoking topography, exposure to nicotine and carbon monoxide, perceptions about the risk of smoking, and intention to stop smoking. The protocol will consist of a randomized experiment via two-week field study. We hypothesize that exposing smokers to messages about filter vents and filters will increase awareness and knowledge of the impact of filter ventilation on cigarette smoking behavior and increase intention to stop smoking. Exposure to messages on packs will also lower ratings of cigarette satisfaction but have no significant impact on smoking behavior, topography, and exposure to nicotine and carbon monoxide.

This is a smoking cessation treatment study. Patients who have a cancer or a suspected cancer who will undergo surgical removal of their cancer are eligible to participate in this study. A novel smoking cessation treatment will be provided to half of the participants in the study. All study participants will receive standard smoking cessation therapy including counseling and the nicotine patch.